📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Azafaros

1.1 - Company Overview

Azafaros Logo

Azafaros

Headquarter: The Netherlands
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of oral azasugar-based therapeutic agents targeting rare lysosomal storage disorders, including the investigational small molecule nizubaglustat for GM1 and GM2 gangliosidoses and Niemann-Pick disease type C. Offers the PRONTO natural history study and the RAINBOW clinical study evaluating nizubaglustat, plus an expanded access policy for AZ-3102 limited to clinical trial participation.

Products and services

  • Nizubaglustat: An orally available small molecule therapeutic engineered to treat rare lysosomal storage diseases, including GM1 and GM2 gangliosidoses and Niemann-Pick disease type C, by reducing harmful lipid accumulation
  • RAINBOW study: A clinical study evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of nizubaglustat in patients with GM2 gangliosidosis or Niemann-Pick disease type C
  • PRONTO study: A prospective longitudinal study aimed at understanding the natural progression of GM1 and GM2 gangliosidoses in children to support future clinical trials

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Azafaros

Scioderm Logo

Scioderm

HQ: United States Website
  • Description: Provider of clinical-stage topical products for the treatment of chronic skin diseases, focused on addressing critical medical needs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Scioderm company profile →
ProFactor Pharma Logo

ProFactor Pharma

HQ: United Kingdom Website
  • Description: Provider of recombinant blood factors for haemophilia, including a low-cost, GMP-optimized recombinant human Factor VIII (rhFVIII) for Haemophilia A. Offers a patent-protected cell line and production process delivering higher yields and lower costs, and collaborates with Bio Farma Persero on scale-up, clinical trials planned to commence in 2024, and commercialization.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ProFactor Pharma company profile →
Brabant Pharma Logo

Brabant Pharma

HQ: Vietnam Website
  • Description: Provider of a late-stage oral treatment, Brabafen, under development for children with Dravet Syndrome (severe myoclonic epilepsy of infancy), a rare childhood epilepsy associated with catastrophic seizures resulting in mental and cognitive impairment.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Brabant Pharma company profile →
Engage Therapeutics Logo

Engage Therapeutics

HQ: United States Website
  • Description: Provider of clinical-stage biopharmaceutical R&D focused on epilepsy, developing Staccato alprazolam, a small, easy-to-use hand-held drug-device combination that leverages an FDA-approved delivery system with FDA-approved alprazolam.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Engage Therapeutics company profile →
Imara Logo

Imara

HQ: United States Website
  • Description: Provider of novel therapeutics for people living with sickle cell disease and hemoglobinopathies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Imara company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Azafaros

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Azafaros

2.2 - Growth funds investing in similar companies to Azafaros

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Azafaros

4.2 - Public trading comparable groups for Azafaros

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Azafaros

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Azafaros

What does Azafaros do?

Azafaros is a provider of oral azasugar-based therapeutic agents targeting rare lysosomal storage disorders, including the investigational small molecule nizubaglustat for GM1 and GM2 gangliosidoses and Niemann-Pick disease type C. Offers the PRONTO natural history study and the RAINBOW clinical study evaluating nizubaglustat, plus an expanded access policy for AZ-3102 limited to clinical trial participation.

Who are Azafaros's competitors?

Azafaros's competitors and similar companies include Scioderm, ProFactor Pharma, Brabant Pharma, Engage Therapeutics, and Imara.

Where is Azafaros headquartered?

Azafaros is headquartered in The Netherlands.

How many employees does Azafaros have?

Azafaros has 1,000 employees 🔒.

When was Azafaros founded?

Azafaros was founded in 2010 🔒.

What sector and industry vertical is Azafaros in?

Azafaros is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Azafaros

Who are the top strategic acquirers in Azafaros's sector and industry

Top strategic M&A buyers and acquirers in Azafaros's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Azafaros?

Top strategic M&A buyers groups and sectors for Azafaros include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Azafaros's sector and industry vertical

Which are the top PE firms investing in Azafaros's sector and industry vertical?

Top PE firms investing in Azafaros's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Azafaros's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Azafaros's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Azafaros's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Azafaros include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Azafaros's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Azafaros?

The key public trading comparables and valuation benchmarks for Azafaros include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Azafaros for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Azafaros with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Azafaros's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Azafaros with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Azafaros's' sector and industry vertical?

Access recent funding rounds and capital raises in Azafaros's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Azafaros